albendazole sulfoxide has been researched along with albendazole in 237 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (9.28) | 18.7374 |
| 1990's | 62 (26.16) | 18.2507 |
| 2000's | 79 (33.33) | 29.6817 |
| 2010's | 63 (26.58) | 24.3611 |
| 2020's | 11 (4.64) | 2.80 |
| Authors | Studies |
|---|---|
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Benoit, E; Besse, S; Delatour, P | 1 |
| Gascon, L; Lanusse, CE; Prichard, RK | 1 |
| Gascon, LH; Lanusse, CE; Nare, B; Prichard, RK | 1 |
| Lanusse, CE; Prichard, RK | 2 |
| Allenmark, SG; Andersson, S; Thompson, RA | 1 |
| Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J | 1 |
| Guo, HF; Jiao, PY; Xiao, SH; You, JQ | 1 |
| Chai, JJ; Jiao, PY; Wang, MJ; Xiao, SH; Yang, B; You, JQ | 1 |
| Awadzi, K; Coventry, PA; Edwards, G; Hoaksey, PE; Orme, ML; Ward, SA | 1 |
| Alvinerie, M; Francheteau, P; Galtier, P; Houin, G; Plusquellec, Y; Steimer, JL | 1 |
| Benoit, E; Caude, I; Delatour, P; Garnier, F | 1 |
| Lanusse, CE; Prichard, RK; Ranjan, S; Trudeau, C | 1 |
| Faustman, EM; Whittaker, SG | 1 |
| Benoit, E; Besse, S; Boukraa, A; Delatour, P | 1 |
| Anderson, N; Jarrett, RG; Martin, PJ | 2 |
| Guo, HF; Jiao, PY; Jiao, W; Xiao, SH; Yang, YQ; You, JQ; Zhang, CW | 1 |
| Morris, DL; Richards, KS; Taylor, DH | 2 |
| Cotting, J; Reichen, J; Steiger, U | 1 |
| Cotting, J; Zeugin, T; Zysset, T | 1 |
| Cotting, J; Reichen, J; Steiger, U; Zeugin, T | 1 |
| Lanusse, CE; Prichard, RK; Ranjan, S | 1 |
| Hurtado, M; Jung, H; Medina, MT; Sotelo, J | 1 |
| Eagleson, GK; Hennessy, DR; Lacey, E; Prichard, RK; Steel, JW | 1 |
| Caude, M; Delatour, P; Lienne, M; Rosset, R; Tambuté, A | 1 |
| Dieckmann-Schuppert, A; Franklin, RM | 1 |
| Morris, DL; Taylor, D | 1 |
| Morris, DL; Taylor, DH | 1 |
| Belkaid, M; Guermouche, MH; Guermouche, S; Jilali, G | 1 |
| Batt, AM; Benoit, E; Fargetton, X; Souhaili-el Amri, H; Totis, M | 1 |
| Batt, AM; Delatour, P; Masson, C; Mothe, O; Siest, G; Souhaili-El Amri, H; Totis, M | 1 |
| Batt, AM; Delatour, P; el Amri, HS; Fargetton, X | 1 |
| Belkaid, M; Chami, K; Guermouche, MH; Guermouche, S; Hamrioui, B; Jilali, G | 1 |
| Chinnery, JB; Morris, DL | 1 |
| Delatour, P; Fargetton, X; Galtier, P | 1 |
| Bogan, JA; Dickson, B; Marriner, SE; Morris, DL | 1 |
| Chinnery, JB; Georgiou, G; Golematis, B; Morris, DL; Stamatakis, G | 1 |
| Alvinerie, M; Delatour, P; Galtier, P | 1 |
| Coulaud, JP; Cremieux, AC; Delaitre, B; Giovanangeli, MD; Hay, JM; Meulemans, A; Saimot, AG | 1 |
| Bogan, JA; Burrows, FG; Dickson, B; Dykes, PW; Marriner, SE; Morris, DL | 1 |
| Fetterer, RH; Rew, RS | 1 |
| Bogan, JA; Marriner, SE; Vandaele, W | 1 |
| Bogan, JA; Marriner, SE | 1 |
| Bodega, G; Casado, N; Denegri, G; Pérez-Serrano, J; Rodríguez-Caabeiro, F | 1 |
| Alvarez, AI; Del Estal, JL; Prieto, JG; Redondo, P; Villaverde, C; Voces, J | 1 |
| Li, B; Ren, H; Xiao, S; You, J; Zhang, C; Zhao, L | 1 |
| Chai, JJ; Jiao, W; Shen, BG; Xiao, SH; Yang, YQ; You, JQ | 1 |
| Casado, N; Pérez-Serrano, J; Rodriguez-Caabeiro, F | 1 |
| Casado, N; Denegri, G; Pérez-Serrano, J; Rodríguez-Caabeiro, F | 3 |
| Hagos, B; Ng'ang'a, JN; Ogeto, JO; Okelo, GB | 1 |
| Craig, PS; Muhmut, M; New, RR; Wen, H; Zhang, HW; Zou, PF | 1 |
| Benchaoui, HA; McKellar, QA; Scott, EW | 1 |
| Lanusse, CE; Nare, B; Prichard, RK | 1 |
| Benchaoui, HA; Futter, IJ; Gettinby, G; Holton, LL; McKellar, QA | 1 |
| Coop, RL; Jackson, F; McKellar, QA | 1 |
| Dominguez, L; Fagiolino, P; Gordon, S; Manta, E | 1 |
| Alvarez, LI; Lanusse, CE; Sanchez, SF; Saumell, CA | 1 |
| Bai, SA; Farin, CE; Piscopo, SE | 1 |
| Botsoglou, NA; Fletouris, DJ; Mantis, AI; Psomas, IE | 1 |
| Bonato, PS; Lanchote, VL; Marques, MP; Takayanagui, OM | 1 |
| Abraham, MH; Mitchell, RC; Takács-Novák, K | 1 |
| Lanusse, C; Lifschitz, A; Mastromarino, M; Virkel, G | 1 |
| Alvarez, LI; Lanusse, CE; Sánchez, SF | 1 |
| Bolás-Fernández, F; Lopez-Garcia, ML; Martínez-Fernández, AR; Torrado-Duran, J; Torrado-Duran, S | 1 |
| Arboix, M; Carretero, A; Cristòfol, C; Manesse, M; Navarro, M; Pérez-Aparicio, FJ; Ruberte, J; Sautet, J | 1 |
| Piscopo, SE; Smoak, IW | 1 |
| Edlind, TD; Katiyar, SK | 1 |
| Bonato, PS; Lanchote, VL; Paias, FO; Takayanagui, OM | 2 |
| Fuentes, I; García, L; Jung, H; Medina, L; Moreno-Esparza, R | 1 |
| Sanyal, PK | 1 |
| Alvarez-de-Felipe, AI; García-Llamazares, JL; Prieto-Fernández, JG; Redondo-Cardeña, PA | 1 |
| Bonato, PS; de Carvalho, R; Lanchote, VL; Marques, MP; Paias, FO; Takayanagui, OM | 1 |
| Drancourt, M; Ridoux, O | 1 |
| Amanvermez, R; Baris, S; Birinci, A; Erzurumlu, K; Hokelek, M; Sahin, M; Tac, K | 1 |
| Camarote, C; Domínguez, L; Fagiolino, P; Malanga, A; Ochoa, A; Quevedo, D; Saldaña, J; Savio, E | 1 |
| Bonato, PS; Lanchote, VL; Marques, MP; Santos, SR; Takayanagui, OM | 1 |
| Bigler, P; Cavaliero, T; Gottstein, B; Hemphill, A; Ingold, K; Thormann, W | 1 |
| Alvarez, AI; Garcia, JL; Larrodé, OM; Merino, G; Prieto, JG; Redondo, PA | 1 |
| Bhagwan, PS; Khan, FA; Sanyal, PK; Singh, D; Swarnkar, CP | 1 |
| Alvarez, C; Cadórniga, R; Torrado, JJ | 1 |
| Asil, M; Deger, BA; Deger, E; Hokelek, M; Pakdemirli, E; Tutar, E | 1 |
| Chouki, M; Procházková, A; Theurillat, R; Thormann, W | 1 |
| Alonso-Villalobos, P; Martinez-Grueiro, MM | 1 |
| Arboix, M; Capece, BP; Castells, G; Cristòfol, C; Pérez, F | 1 |
| Alvarez, L; Lanusse, C; Sallovitz, J; Sánchez, S | 1 |
| Lanusse, CE; Rodriguez, JA; Solana, HD | 1 |
| Arboix, M; Calsamiglia, S; Capece, BP; Castells, G; Cristòfol, C | 1 |
| Alvarez, L; Arboix, M; Cristofol, C; Lanusse, C; Sánchez, S; Virkel, G | 1 |
| Errecalde, JO; Formentini, EA; Mariño, EL; Mestorino, ON | 1 |
| Gottstein, B; Hemphill, A; Lawton, P; Sarciron, E; Siles-Lucas, M; Stettler, M | 1 |
| Alvarez, L; Arboix, M; Cristòfol, C; Lanusse, CE; Virkel, G | 1 |
| Alvarez, LI; Lanusse, CE; Mottier, ML; Sánchez, SF | 1 |
| Procházková, A; Prost, F; Thormann, W | 1 |
| Lanusse, C; Lifschitz, A; Pis, A; Virkel, G | 1 |
| Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM | 1 |
| Bin, L; Cheng, F; Hotez, P; Junjie, C; Mingjie, W; Shuhua, X; Weixia, S | 1 |
| Andaluz, A; Arboix, M; Capece, BP; Castells, G; Cristòfol, C; Garcia, F; Pérez, F; Pérez, R | 1 |
| Bonato, PS; Dreossi, SA; Lanchote, VL; Takayanagui, OM | 1 |
| Dadashzadeh, S; Mirfazaelian, A; Rouini, MR | 2 |
| Bonato, PS; Lanchote, VL; Takayanagui, OM | 1 |
| Bernal, JL; del Nozal, MJ; Jiménez, JJ; Nieto, EM; Toribio, L | 1 |
| Arboix, M; Arcalis, T; Capece, BP; Carretero, A; Castells, G; Cristòfol, C; Navarro, M; Perez, F; Ruberte, J; Toribio, L | 1 |
| Felipe, AE; Lanusse, CE; Sallovitz, JM; Solana, HD; Teruel, MT | 1 |
| Addy, ET; Ardrey, AE; Attah, SK; Awadzi, K; Duke, BO; Edwards, G; Opoku, NO; Quartey, BT | 1 |
| Alvarez, AI; García, JL; Merino, G; Molina, AJ; Prieto, JG; Pulido, MM | 3 |
| Balarinová, R; Baliharová, V; Lamka, J; Skálová, L; Velík, J | 1 |
| Bernal, JL; Nieto, EM; Nozal, MJ; Toribio, L | 1 |
| Goudah, A | 1 |
| Dash, AP; Dua, VK; Sarin, R | 1 |
| Cuesta-Bandera, C; Daniel-Mwuambete, K; Ponce-Gordo, F; Torrado, J; Torrado, S | 1 |
| Cuesta-Bandera, C; Daniel-Mwambete, K; Ponce-Gordo, F; Torrado, JJ; Torrado, S | 1 |
| Inza, G; Lanusse, C; Lifschitz, A; Sallovitz, J; Virkel, G | 1 |
| Batzias, GC; Delis, GA | 1 |
| Bolás-Fernández, F; Rama-Iñiguez, S; Torrado, JJ | 1 |
| Chanthavanich, P; Kabkaew, K; Lapphra, K; Limkittikul, K; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sirivichayakul, C; Subchareon, A; Wisetsing, P | 1 |
| Anziani, OS; Coles, GC; Grande, H; Guglielmone, AA; Suarez, V; Warnke, O | 1 |
| Lanchote, VL; Mateus, FH; Takayanagui, OM | 1 |
| Batzias, GC; Delis, GA; Theodosiadou, E | 1 |
| Fairweather, I; Hoey, L; McFerran, N; Robinson, MW; Trudgett, A | 1 |
| Hong, Z; Liren, C; Xiaomei, W; Xingping, L; Yanping, S; Yongmin, L; Zongde, Z | 1 |
| Chen, L; Dun, H; Li, Y; Liu, C; Zhai, Z; Zhang, H | 1 |
| Fletouris, DJ; Nakos, DS; Papapanagiotou, EP; Psomas, IE | 1 |
| Medlicott, NJ; Razzak, M; Tucker, IG; Wu, Z | 4 |
| Fonseca, F; Mansilla, JA; Manterola, C | 1 |
| Baliharová, V; Lamka, J; Skálová, L; Szotáková, B; Velík, J; Wsól, V | 1 |
| Errecalde, JO; Formentini, EA; Mestorino, N | 1 |
| Abuagob, O; Benothman, M; Bishop, SC; Innocent, G; Kerr, A; Mitchell, S; Stear, MJ | 1 |
| Hanpitakpong, W; Kietinun, S; Lazdins, J; Na-Bangchang, C; Na-Bangchang, K; Pawa, KK | 1 |
| Ambrosio, JR; Jung-Cook, H; Ortiz, A; Palencia, G; Palomares, F | 1 |
| Cringoli, G; Genchi, C; Rinaldi, L; Veneziano, V | 1 |
| Alvarez, AI; Mendoza, G; Merino, G; Molina, AJ; Prieto, JG; Pulido, MM | 1 |
| Cirak, VY; Gokbulut, C; Senlik, B | 1 |
| Jung-Cook, H; Ortiz-Plata, A; Palencia, G; Palomares-Alonso, F; Piliado, JC | 1 |
| Bonato, PS; de Oliveira, AR; de Santana, FJ; Fernandes, BJ; Garcia, HH; Gonzalez, AE; Lanchote, VL; Takayanagui, OM | 1 |
| Alvarez, AI; Mendoza, G; Merino, G; Molina, AJ; Prieto, JG; Real, R | 1 |
| Arboix, M; Capece, BP; Castells, G; Cristòfol, C; Godoy, C | 1 |
| Chaudhary, PL; Dubey, AK; Koley, KM; Mandal, SC; Mukherjee, K; Pal, S; Sanyal, PK | 1 |
| Cvilink, V; Ketola, RA; Kostiainen, R; Lamka, J; Skálová, L; Szotáková, B | 1 |
| Gnoth, MJ; Grieshop, B; Ickenroth, K; Muenster, U | 1 |
| Cvilink, V; Krízová, V; Lamka, J; Skálová, L; Szotáková, B | 1 |
| Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Jung-Cook, H; López-Balbiaux, N; Palencia-Hernández, G; Palomares-Alonso, F; Pérez-Villanueva, J; Piliado, JC; Rodríguez-Morales, S | 1 |
| Belaz, KR; Cass, QB; Oliveira, RV | 1 |
| Ceriani, C; Lanusse, C; Rodríguez, J; Scarcella, S; Solana, H; Virkel, G | 1 |
| Afonso, SM; Capece, BP; Castells, G; Cristòfol, C; Godoy, C; Harun, M; Lazáro, R | 1 |
| Gunes, E; Perim, G; Senol, G; Tatar, D; Unsal, S | 1 |
| Cirak, VY; Gokbulut, C; McKellar, QA; Senlik, B; Yildirim, F | 1 |
| Adas, G; Arikan, S; Karatepe, O; Kemik, O; Oner, A; Sahip, N | 1 |
| Capece, BP; Lanusse, CE; Virkel, GL | 1 |
| Bao, GS; Jing, T; Qiao, H; Wang, J; Zhang, H | 1 |
| Capan, M; Jäger, W; Keltner, S; Ramharter, M; Thalhammer, F; Winkler, S; Zeitlinger, M | 1 |
| Brundage, RC; Castro, N; Góngora, F; González-Esquivel, D; Jara, A; Jung, H; Lanao, JM; Márquez-Caraveo, C; Suárez, AM; Urizar, J | 1 |
| Abdel-tawab, AM; Bradley, M; el-Setouhy, M; Ghazaly, EA; Horton, J | 1 |
| Bártíková, H; Lamka, J; Skálová, L; Szotáková, B; Vokřál, I | 1 |
| Ambrosio, JR; García-Vilchis, D; Reynoso-Ducoing, O; Trejo-Chávez, H | 1 |
| McSporran, K; Medlicott, NJ; Razzak, M; Tucker, IG; Wu, Z; Yang, L | 1 |
| McSporran, K; Medlicott, NJ; Razzak, M; Tucker, IG; Wu, Z | 1 |
| Girisham, S; Reddy, SM; Shyam Prasad, G | 1 |
| Butler, V; Gilleard, JS; Ivens, A; Laing, R; Laing, ST; Ravikumar, S; Woods, DJ | 1 |
| Bártíková, H; Forstová-Křížová, V; Lamka, J; Skálová, L; Szotáková, B; Vokřál, I | 1 |
| Grabowski, T; Jaroszewski, JJ; Markiewicz, W; Maślanka, T; Sawicka, R; Swierczewska, A; Ziółkowski, H | 1 |
| Allemandi, D; Cabrera, P; Castro, S; Dib, A; Farías, C; Lanusse, C; Moreno, L; Palma, S; Sánchez Bruni, S; Suárez, G | 1 |
| Giri, S; Kandaswamy, M; Meena, AK; Mithra, C; Mullangi, R; Rajagopal, S; Sharma, K | 1 |
| Catalano, R; Dercole, J; Teruel, M | 1 |
| Cárdenas, G; González-Hernández, I; Jung-Cook, H; Ruiz-Olmedo, MI | 1 |
| Alvarez, L; Ceballos, L; Lanusse, C; Moreno, L; Suárez, G | 1 |
| Barth, T; Bonato, PS; Borges, KB; Carrão, DB; de Oliveira, AR; Pupo, MT | 1 |
| Ai, D; Cao, J; Chen, C; Li, J; Li, Z; Qi, Y; Shen, H; Wang, C; Yi, W | 1 |
| Barth, T; Borges, KB; Carrão, DB; de Oliveira, AR; Furtado, NA; Hilário, VC; Pupo, MT | 1 |
| Batista, JM; Cass, QB; Furlan, M; He, Y; Lourenço, TC; Nafie, LA; Santana, CC | 1 |
| Almeida, AP; Belaz, KR; Cass, QB; Denadai, M; Lima, RT; Oliveira, RV; Pinto, MM; Vasconcelos, MH | 1 |
| Eckardt, K; Kaltenhäuser, J; Kilb, C; Seiler, A; Stahlmann, R | 1 |
| Cass, QB; de Campos Lourenço, T; Dorny, P; García, HH; Guerra-Giraldez, C; Mahanty, S; Marzal, M; Nash, TE; Paredes, A; Rivera, A | 1 |
| Ambrosio, JR; Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Márquez-Navarro, A; Pérez-Reyes, A; Reynoso-Ducoing, O; Yépez-Mulia, L; Zepeda-Rodríguez, A | 1 |
| da Costa, LF; de Castro, JM; Lallo, MA | 1 |
| Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P | 1 |
| Ahmadnia, S; Moazeni, M; Mohammadi-Samani, S; Oryan, A | 1 |
| Buzzulini, C; Cruz, BC; da Costa, AJ; de Oliveira, GP; Felippelli, G; Lopes, WD; Maciel, WG; Nunes, JL; Pereira, JC; Soares, VE; Soccol, VT; Teixeira, WF | 1 |
| Carradori, S; Cirilli, R; Ferretti, R; Gallinella, B; Materazzo, S; Secci, D | 1 |
| Alvarez, L; Castells, D; Fagiolino, P; Lanusse, C; Moreno, L; Suarez, G | 1 |
| Allemandi, D; Bruni, SS; Castro, S; Elissondo, MC; Palma, SD; Pensel, PE | 1 |
| Desnica, B; Runje, M; Skuhala, T; Trkulja, V; Vukelic, D | 1 |
| Jin, L; Li, T; Shi, H; Sun, X; Zhang, X | 1 |
| Alvarez, L; Bistoletti, M; Lanusse, C; Moreno, L | 1 |
| Liang, W; Ma, X; Peng, XY; Sun, H; Wang, XC; Wu, XW; Zhang, SJ | 1 |
| Li, L; Li, QR; Xiao, Y; Xing, DX; Yang, Q; Ye, MQ | 1 |
| Fazzio, LE; Galvan, WR; Gimeno, EJ; Giudici, CJ; Sánchez, RO; Streitenberger, N | 1 |
| Belaz, KR; da Silva, CA; de O Cardoso, J; Oliveira, RV | 1 |
| Aksit, D; Ayaz, E; Boyacioğlu, M; Cirak, VY; Gokbulut, C; Sekkin, S; Yalinkilinc, HS | 1 |
| Bharkad, GP; Devarajan, PV; Shinde, RL | 1 |
| Ambrosio, J; Castillo, R; Da Costa, TL; De Castro, AM; Fraga, CM; Hernández-Campos, A; Reynoso-Ducoing, O; Vinaud, MC | 2 |
| Alkan, E; Burul-Bozkurt, N; Fikirdeşici, E; Güney, B; Özkan, GY; Sağlam, O; Saraner, N; Yıldırım, M | 1 |
| Auer, H; Groger, M; Kaczirek, K; Lötsch, F; Naderer, J; Ramharter, M; Skuhala, T; Waneck, F | 1 |
| Fazzio, LE; Galvan, WR; Gimeno, EJ; Sanabria, RE; Sánchez, RO; Streitenberger, N | 1 |
| Hengsawas Surasarang, S; Huang, S; Keen, JM; McGinity, JW; Williams, RO; Zhang, F | 1 |
| Ahmadpour, E; Akbari, NA; Akbarzadeh, A; Mahami-Oskouei, M; Naseri, M; Spotin, A | 1 |
| Cezar, RSM; Coaglio, AL; Conzensa, G; Lima, WS; Mendes, T; Oliveira, FLP; Oliveira, LLS; Pereira, CAJ; Santos, FSO | 1 |
| da Costa, TL; de A Picanço, G; de Lima, NF; de S Lino Junior, R; de S M M Alves, D; Fraga, CM; Isac, E; Vinaud, MC | 1 |
| García, JP; Lanusse, CE; Lifschitz, AL; Maté, ML; Quiroga, MA; Virkel, GL; Viviani, P | 1 |
| Busatto, Z; da Silva, AF; de Freitas, O; Paschoal, JA | 1 |
| Bhutani, H; Feng, Y; Wang, F; Ye, B; Zhang, XW | 1 |
| Alvarez, L; Bernat, G; Canton, C; Ceballos, L; Domingo Yagüez, P; Fiel, C; Lanusse, C; Moreno, L | 1 |
| Carradori, S; Casulli, A; Cirilli, R; Formica, FR; Guglielmi, P | 1 |
| Cowan, N; Keiser, J; Meier, C; Neodo, A | 1 |
| Alvarez, L; Bernat, G; Canton, C; Ceballos, L; Domínguez, MP; Farías, C; Fiel, C; Lanusse, C; Moreno, L | 1 |
| Ambrosio, J; Castillo, R; da Costa, TL; de Andrade Picanço, G; de Lima, NF; Fraga, CM; Isac, E; Vinaud, MC | 1 |
| Lamas, MC; Leonardi, D; Pico, G; Priotti, J | 1 |
| Lv, P; Ming, L; Peng, RY; Ren, HJ; Wei, GH; Zhang, CL | 1 |
| Dimunová, D; Lamka, J; Matoušková, P; Nguyen, LT; Sečkařová, A; Skálová, L; Stuchlíková, LR; Szotáková, B; Várady, M; Vokřál, I | 1 |
| Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR | 1 |
| Baglioni, MV; García, A; Lamas, MC; Leonardi, D; Menacho Márquez, M; Priotti, J; Rico, MJ | 1 |
| Carrillo-Mezo, R; Fleury, A; González-Hernández, I; Jung, H; Matus, C; Osorio, R; Romo, ML; Toledo, A | 1 |
| Arroyo, G; Bonato, PS; Bustos, JA; Garcia, HH; Gilman, RH; Gonzales, I; Gonzalez, AE; Horton, J; Lanchote, VL; Lescano, AG; Pretell, EJ; Rodriguez, S; Saavedra, H; Takayanagui, OM | 1 |
| Donnelly, RF; McCarthy, HO; Permana, AD; Tekko, IA | 1 |
| Alves, DSMM; Costa, TL; Fraga, CM; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Vinaud, MC | 1 |
| Allemandi, DA; Camacho, NM; Dib, A; Lanusse, C; Litterio, N; Palma, SD; Paredes, AJ; Sánchez Bruni, S; Schofs, L; Zarazaga, MDP | 1 |
| Barberis, ME; Camacho, NM; Palma, SD; Real, JP; Sánchez Bruni, S | 1 |
| Kellerová, P; Lamka, J; Matoušková, P; Navrátilová, M; Raisová Stuchlíková, L; Skálová, L; Štěrbová, K; Szotáková, B; Vokřál, I | 1 |
| Carradori, S; Casulli, A; Cirilli, R; Fabiani, M; Harem, IS; Hemphill, A; Kocak, M; Kurt, A; Lundström-Stadelmann, B; Sciamanna, I; Siles-Lucas, M; Vural, G; Yardimci, M; Yasar, TÖ | 1 |
| Bolger, MB; Chronowska, M; Kostewicz, ES; Pettarin, M | 1 |
| Abedi, M; Alizadeh, M; Darvishi, MM; Moazeni, M; Tamaddon, AM | 1 |
| Alipanahpour Dil, E; Asfaram, A; Javadian, H | 1 |
| Avci, H; Ayaz, E; Aypak, S; Boga, B; Cirak, VY; Gokbulut, C; Sekkin, S; Yalinkilinc, HS | 1 |
| Barberis, ME; Bermúdez, JM; Gonzo, EE; Ibarra, M; Lorier, M; Palma, SD; Real, JP | 1 |
| Basáñez, MG; Boussinesq, M; Chesnais, CB; Kamgno, J; Pion, SDS; Walker, M; Whittaker, C | 1 |
3 review(s) available for albendazole sulfoxide and albendazole
| Article | Year |
|---|---|
Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications.
Topics: Albendazole; Animals; Animals, Domestic; Anthelmintics; Fenbendazole; Intestinal Diseases, Parasitic; Molecular Structure | 2009 |
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Topics: Albendazole; Animals; Anthelmintics; Cysts; Echinococcosis; Echinococcus granulosus; Humans; Praziquantel | 2016 |
Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis.
Topics: Administration, Oral; Adult; Albendazole; Anthelmintics; Child; Echinococcosis; Humans | 2022 |
21 trial(s) available for albendazole sulfoxide and albendazole
| Article | Year |
|---|---|
Sensitivity to albendazole sulphoxide of Echinococcus granulosus scoleces in man.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Clinical Trials as Topic; Echinococcosis; Echinococcus; Humans | 1986 |
Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis.
Topics: Albendazole; Anthelmintics; Bile; Chromatography, High Pressure Liquid; Cimetidine; Drug Therapy, Combination; Echinococcosis; Humans | 1994 |
Bioavailability of different benzimidazole volume-dose formulations in sheep.
Topics: Albendazole; Animals; Anthelmintics; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Sheep; Suspensions | 1995 |
Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
Topics: Adult; Albendazole; Animals; Anthelmintics; Biological Availability; Cross-Over Studies; Female; Humans; Male; Rats; Rats, Wistar; Solubility | 1995 |
Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cimetidine; Cysticercosis; Dexamethasone; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1997 |
Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase.
Topics: Adult; Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Cysticercosis; Female; Humans; Kinetics; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Stereoisomerism | 1997 |
Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
Topics: Adult; Albendazole; Anthelmintics; Cross-Over Studies; Double-Blind Method; Humans | 1998 |
Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Neurocysticercosis; Spectrometry, Fluorescence; Stereoisomerism | 1999 |
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Female; Humans; Isomerism; Male; Neurocysticercosis; Phenobarbital; Phenytoin | 2002 |
Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.
Topics: Administration, Oral; Adult; Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Echinococcosis; Emulsions; Humans; Male; Mice; Soybean Oil; Therapeutic Equivalency; Treatment Outcome | 2002 |
Placental and fetal toxicity of albendazole sulphoxide in Wistar rats.
Topics: Abnormalities, Multiple; Administration, Oral; Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Female; Fetus; Limb Deformities, Congenital; Placenta; Pregnancy; Rats; Rats, Wistar | 2003 |
Time dependent pharmacokinetics of albendazole in human.
Topics: Administration, Oral; Adult; Albendazole; Anthelmintics; Area Under Curve; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Liver; Male; Time Factors | 2003 |
The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Topics: Administration, Oral; Adult; Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis | 2003 |
Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis.
Topics: Administration, Oral; Albendazole; Anthelmintics; Child; Drug Therapy, Combination; Female; Giardiasis; Humans; Male; Praziquantel | 2004 |
Preoperative albendazole and scolices viability in patients with hepatic echinococcosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Drug Administration Schedule; Echinococcosis, Hepatic; Echinococcus; Female; Humans; Male; Middle Aged; Premedication; Treatment Failure | 2005 |
Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
Topics: Albendazole; Animals; Anthelmintics; Injections, Intravenous; Injections, Subcutaneous; Rumen; Sheep | 2005 |
Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations.
Topics: Adult; Albendazole; Anthelmintics; Antiparasitic Agents; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Ivermectin; Male; Praziquantel | 2006 |
A dual anthelmintic treatment strategic scheme for the control of fasciolosis in dairy sheep farms.
Topics: Albendazole; Animals; Antiplatyhelmintic Agents; Dairying; Fasciola hepatica; Fascioliasis; Feces; Female; Hares; Italy; Lactation; Longitudinal Studies; Parasite Egg Count; Prevalence; Rafoxanide; Seasons; Sheep Diseases; Sheep, Domestic | 2006 |
Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Feces; Female; Guanidines; Helminthiasis, Animal; Sheep; Sheep Diseases | 2006 |
Dose-dependent systemic exposure of albendazole metabolites in lambs.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Gastrointestinal Tract; Half-Life; Sheep | 2012 |
Efficacy and productive performance of moxidectin in feedlot calves infected with nematodes resistant to ivermectin.
Topics: Albendazole; Animals; Cattle; Cattle Diseases; Drug Resistance; Female; Ivermectin; Levamisole; Macrolides; Nematoda; Nematode Infections | 2016 |
213 other study(ies) available for albendazole sulfoxide and albendazole
| Article | Year |
|---|---|
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
Topics: Albendazole; Animals; Anthelmintics; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Goats | 1992 |
Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, High Pressure Liquid; Female; Guanidines; Injections, Intramuscular; Methimazole; Sheep | 1992 |
Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle.
Topics: Abomasum; Albendazole; Animals; Anthelmintics; Body Fluids; Cattle; Inactivation, Metabolic; Intestinal Mucosa; Oxidation-Reduction; Rumen; Sheep; Stomach, Ruminant | 1992 |
Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, High Pressure Liquid; Drug Interactions; Guanidines; Injections, Intramuscular; Male; Methimazole; Sheep | 1992 |
Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases. IX. Influence of the cross-linking reagent on the retentive and enantioselective properties of chiral sorbents based on bovine serum albumin.
Topics: Albendazole; Anthelmintics; Benzodiazepinones; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Stereoisomerism | 1992 |
Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.
Topics: Administration, Oral; Adult; Aged; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Time Factors | 1992 |
Enhancement of the plasma concentration of albendazole sulphoxide in sheep following coadministration of parenteral netobimin and liver oxidase inhibitors.
Topics: Albendazole; Animals; Anthelmintics; Drug Interactions; Guanidines; Injections, Intramuscular; Injections, Subcutaneous; Liver; Male; Methimazole; Metyrapone; Oxidation-Reduction; Oxidoreductases; Quinine; Sheep | 1991 |
[Uptake and release of mebendazole, albendazole and albendazole sulfoxide by secondary cysts of Echinococcus granulosus in vitro].
Topics: Albendazole; Animals; Anthelmintics; Echinococcus; Mebendazole; Mice | 1991 |
[Pharmacokinetics of four benzimidazoles administered intragastrically to mice infected with secondary cysts of Echinococcus granulosus].
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Female; Mebendazole; Mice; Stomach | 1991 |
Rapid and sensitive method for the determination of albendazole and albendazole sulphoxide in biological fluids.
Topics: Adult; Albendazole; Chromatography, High Pressure Liquid; Humans; Male; Methylene Chloride; Middle Aged; Onchocerciasis | 1991 |
Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheep.
Topics: Administration, Oral; Albendazole; Animals; Injections; Injections, Intravenous; Male; Mathematics; Metabolic Clearance Rate; Models, Biological; Molecular Structure; Rumen; Sheep | 1991 |
Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
Topics: Administration, Oral; Albendazole; Animals; Cattle; Chromatography, Liquid; Goats; Isomerism; Sheep | 1991 |
Pharmacokinetic profiles of netobimin metabolites after oral administration of zwitterion and trisamine formulations of netobimin to cattle.
Topics: Administration, Oral; Albendazole; Animals; Cattle; Guanidines; Male; Tromethamine | 1991 |
Effects of albendazole and albendazole sulfoxide on cultures of differentiating rodent embryonic cells.
Topics: Albendazole; Animals; Cell Differentiation; Cell Survival; Cells, Cultured; Dimethyl Sulfoxide; Embryo, Mammalian; Extremities; Fluorescent Antibody Technique; Immunohistochemistry; Mesencephalon; Microtubules; Neutral Red; Rats; Rats, Inbred Strains; Tubulin | 1991 |
Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
Topics: Albendazole; Animals; Chromatography, High Pressure Liquid; Dogs; Humans; Kinetics; Male; Rats; Rats, Inbred Strains; Stereoisomerism | 1991 |
The efficacy of mixtures of albendazole sulphoxide and levamisole against sheep nematodes resistant to benzimidazole and levamisole.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Feces; Levamisole; Ostertagia; Ostertagiasis; Parasite Egg Count; Sheep; Sheep Diseases; Trichostrongyloidiasis; Trichostrongylosis; Trichostrongylus | 1991 |
Field evaluation of a mixture of albendazole sulphoxide and levamisole against Ostertagia and Trichostrongylus spp in sheep.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Feces; Levamisole; Ostertagia; Ostertagiasis; Parasite Egg Count; Sheep; Sheep Diseases; Trichostrongyloidiasis; Trichostrongylosis; Trichostrongylus | 1991 |
[Effect of mebendazole, albendazole and albendazole sulfoxide on glycogen contents of Echinococcus granulosus cysts in infected mice].
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Echinococcus; Female; Glycogen; Mebendazole; Mice | 1990 |
Perioperative prophylactic chemotherapy of Echinococcus granulosus: determination of minimum effective length of albendazole therapy in in vitro protoscolex culture.
Topics: Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Drug Administration Schedule; Echinococcosis; Echinococcus; Humans; In Vitro Techniques; Intraoperative Period; Postoperative Period | 1990 |
Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance.
Topics: Adult; Aged; Albendazole; Aminopyrine; Breath Tests; Drug Tolerance; Echinococcosis, Hepatic; Echinococcosis, Pulmonary; Female; Humans; Liver; Liver Function Tests; Male; Microsomes; Microsomes, Liver; Middle Aged; Neutropenia; Prospective Studies | 1990 |
Therapeutic monitoring of albendazole: a high-performance liquid chromatography method for determination of its active metabolite albendazole sulfoxide.
Topics: Albendazole; Chromatography, High Pressure Liquid; Humans; Monitoring, Physiologic | 1990 |
Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis.
Topics: Adult; Aged; Albendazole; Cholestasis; Echinococcosis; Female; Half-Life; Humans; Intestinal Absorption; Male; Middle Aged | 1990 |
Comparison of pharmacokinetic variables for two injectable formulations of netobimin administered to calves.
Topics: Albendazole; Animals; Cattle; Chemistry, Pharmaceutical; Guanidines; Half-Life; Injections, Subcutaneous; Time Factors | 1990 |
Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid.
Topics: Albendazole; Chromatography, High Pressure Liquid; Humans; Mebendazole | 1989 |
The disposition of albendazole in sheep.
Topics: Albendazole; Animals; Bile; Male; Molecular Structure; Sheep | 1989 |
Direct separation of albendazole sulfoxide enantiomers by liquid chromatography on a chiral column deriving from (S)-N-(3,5-dinitrobenzoyl) tyrosine: application to enantiomeric assays on plasma samples.
Topics: Albendazole; Animals; Cattle; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Nitrobenzoates; Rats; Sheep; Solvents; Spectrophotometry, Ultraviolet; Stereoisomerism; Temperature; Tyrosine | 1989 |
Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro.
Topics: Actins; Albendazole; Animals; Anthelmintics; Antimalarials; Antineoplastic Agents; Benzimidazoles; Cytochalasin B; Cytoskeletal Proteins; Demecolcine; Dioxolanes; Drug Resistance; Erythrocytes; Humans; Mebendazole; Nocodazole; Plasmodium falciparum; Tubulin; Vinblastine; Vincristine | 1989 |
Combination chemotherapy of Echinococcus granulosus--in vitro studies.
Topics: Albendazole; Animals; Benzimidazoles; Drug Therapy, Combination; Echinococcosis; Praziquantel | 1988 |
In vitro culture of Echinococcus multilocularis: protoscolicidal action of praziquantel and albendazole sulphoxide.
Topics: Albendazole; Animals; Benzimidazoles; Echinococcosis; In Vitro Techniques; Parasitology; Praziquantel; Rats | 1988 |
[Study of the distribution of albendazole sulfoxide by liquid chromatography in plasma and cyst fluid in hydatidosis].
Topics: Albendazole; Anthelmintics; Benzimidazoles; Chromatography, Liquid; Echinococcosis; Humans | 1988 |
Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics.
Topics: Administration, Oral; Albendazole; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Enzyme Induction; Male; Microsomes, Liver; Oxygenases; Rats; Rats, Inbred Strains | 1988 |
Albendazole sulfonation by rat liver cytochrome P-450c.
Topics: Albendazole; Animals; Anthelmintics; Aroclors; Benzimidazoles; Biotransformation; Chlorodiphenyl (54% Chlorine); Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Male; Methylcholanthrene; Microsomes, Liver; Rats; Rats, Inbred Strains; Safrole | 1988 |
Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes.
Topics: Albendazole; Animals; Benzimidazoles; Catalysis; Cytochrome P-450 Enzyme System; Flavin-Adenine Dinucleotide; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Substrate Specificity; Swine | 1987 |
[Variation of albendazole sulfoxide concentrations in serum, hydatid cyst membrane and liquid as a function of time. Liquid phase chromatographic study].
Topics: Albendazole; Animals; Benzimidazoles; Chromatography, High Pressure Liquid; Echinococcosis; Mice | 1987 |
Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Dose-Response Relationship, Drug; Echinococcus; Gerbillinae; In Vitro Techniques | 1986 |
Sulfoxidation of albendazole by a cytochrome P450-independent monooxygenase from rat liver microsomes.
Topics: Albendazole; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Kinetics; Male; Microsomes, Liver; Oxygenases; Rats; Rats, Inbred Strains | 1986 |
Pharmacokinetics of albendazole in man.
Topics: Absorption; Adipose Tissue; Adult; Albendazole; Anthelmintics; Benzimidazoles; Echinococcosis; Female; Humans; Kinetics; Male | 1986 |
Penetration of albendazole sulphoxide into hydatid cysts.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Biological Availability; Echinococcosis; Gerbillinae; Humans; Sheep | 1987 |
In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Hydrogen-Ion Concentration; Kinetics; Male; Microsomes, Liver; NADP; Oxidation-Reduction; Sheep | 1986 |
Albendazole as a potential treatment for human hydatidosis.
Topics: Administration, Oral; Adult; Albendazole; Anthelmintics; Antibodies; Benzimidazoles; Child; Echinococcosis; Echinococcosis, Hepatic; Echinococcus; Female; Humans; Male; Middle Aged; Preoperative Care | 1983 |
Albendazole in hydatid disease.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Echinococcosis; Female; Humans | 1983 |
Interaction of Fasciola hepatica with albendazole and its metabolites.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Carbon Dioxide; Cattle; Fasciola hepatica; Glucose; Oxidation-Reduction; Sheep | 1984 |
Comparison of the pharmacokinetics of albendazole and its major metabolites after oral administration of albendazole as a suspension and as a paste formulation to sheep.
Topics: Abomasum; Administration, Oral; Albendazole; Animals; Benzimidazoles; Kinetics; Ointments; Rumen; Sheep; Suspensions; Time Factors | 1981 |
Pharmacokinetics of albendazole in sheep.
Topics: Abomasum; Albendazole; Animals; Benzimidazoles; Female; Male; Sheep; Sulfones; Sulfoxides | 1980 |
Anti-tubulin immunohistochemistry study of Echinococcus granulosus protoscolices incubated with albendazole and albendazole sulphoxide in vitro.
Topics: Albendazole; Animals; Antibodies, Helminth; Cattle; Echinococcus; Immunohistochemistry; Sheep; Tubulin | 1995 |
Small intestinal sulphoxidation of albendazole.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Carbon Monoxide; Enzyme Induction; Female; In Vitro Techniques; Intestine, Small; Methimazole; Microsomes; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Rats; Rats, Wistar | 1995 |
Effect of albendazole on Ancylostoma caninum larvae migrating in the muscles of mice.
Topics: Albendazole; Ancylostoma; Ancylostomiasis; Animals; Female; Larva; Larva Migrans; Male; Mice; Muscle, Skeletal | 1994 |
Effects of benzimidazole compounds on mice infected with secondary cysts of Echinococcus granulosus.
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Echinococcus; Female; In Vitro Techniques; Mebendazole; Mice | 1994 |
The effects of albendazole and albendazole sulphoxide combination-therapy on Echinococcus granulosus in vitro.
Topics: Albendazole; Animals; Anthelmintics; Culture Media; Drug Combinations; Echinococcus; Microscopy, Electron; Microscopy, Electron, Scanning | 1994 |
Development of truncated microtriches in Echinococcus granulosus protoscolices.
Topics: Albendazole; Animals; Echinococcus; Ivermectin; Microscopy, Electron | 1994 |
Pharmacokinetics of albendazole in children with hydatid disease.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Albendazole; Anthelmintics; Child; Drug Monitoring; Echinococcosis; Evaluation Studies as Topic; Humans; Male; Time Factors | 1993 |
Pharmacokinetics of albendazole, albendazole sulfoxide and netobimin in goats.
Topics: Absorption; Administration, Oral; Albendazole; Animals; Anthelmintics; Biological Availability; Goats; Guanidines; Half-Life; Random Allocation | 1993 |
Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole.
Topics: Albendazole; Animals; Binding Sites; Cattle; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; In Vitro Techniques; Methimazole; Microsomes, Liver; NADP; Oxidation-Reduction; Oxygenases; Sheep; Sulfoxides; Thiourea | 1993 |
The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month- and eight-month-old sheep.
Topics: Aging; Albendazole; Animals; Anthelmintics; Female; Guanidines; Male; Sheep | 1995 |
Plasma disposition kinetics of albendazole metabolites in pigs fed different diets.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Diet; Dietary Proteins; Female; Food, Fortified; Male; Milk Proteins; Poaceae; Swine; Time Factors; Whey Proteins | 1996 |
Determination of concentration of albendazole sulfoxide in plasma and uterine fluid of heifers.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Cattle; Chromatography, High Pressure Liquid; Female; Random Allocation; Time Factors; Uterus | 1997 |
Trace analysis of albendazole and its sulphoxide and sulphone metabolites in milk by liquid chromatography.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Chromatography, Liquid; Feasibility Studies; Female; Milk; Reproducibility of Results; Sensitivity and Specificity; Sulfones; Sulfoxides | 1996 |
On the partition of ampholytes: application to blood-brain distribution.
Topics: Albendazole; Anti-Infective Agents; Blood-Brain Barrier; Buffers; Ciprofloxacin; Cyclohexanes; Fluoroquinolones; Hydrogen-Ion Concentration; Morphine; Niflumic Acid; Nitrazepam; Octanols; Pharmaceutical Preparations; Solubility; Structure-Activity Relationship; Sulfamethazine; Water | 1997 |
Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Fasting; Female; Random Allocation; Sheep; Time Factors | 1997 |
Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
Topics: Abomasum; Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Haemonchiasis; Half-Life; Male; Sheep; Sheep Diseases | 1997 |
Development of chemotherapeutic model for the in vitro screening of drugs against Echinoccus granulosus cysts: the effects of an albendazole-albendazole sulphoxide combination.
Topics: Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echinococcosis; Echinococcus; In Vitro Techniques; Sheep; Sheep Diseases | 1996 |
Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
Topics: Albendazole; Animals; Anthelmintics; Female; Intestinal Diseases, Parasitic; Mice; Muscles; Trichinella spiralis; Trichinellosis | 1997 |
Study of the distribution of albendazole-sulphoxide (ABZ-SO) in fertilized egg compartments.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Chick Embryo; Chickens; Egg Yolk; Female; Male; Tissue Distribution; Toxicity Tests; Weights and Measures; Zygote | 1997 |
Comparison of effects of albendazole sulfoxide on in vitro produced bovine embryos and rat embryos.
Topics: Abnormalities, Drug-Induced; Albendazole; Animals; Anthelmintics; Blastomeres; Cattle; Cell Division; Embryo, Mammalian; Embryonic and Fetal Development; Female; Fertilization; Fertilization in Vitro; Gestational Age; Male; Morula; Rats; Rats, Sprague-Dawley | 1997 |
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Benzimidazoles; Chlorocebus aethiops; Encephalitozoon; Encephalitozoonosis; Humans; Vero Cells | 1997 |
In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Drug Combinations; Echinococcosis; Female; Mice; Mice, Inbred Strains | 1997 |
Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide.
Topics: Albendazole; Animals; Anthelmintics; Digestive System; In Vitro Techniques; Intestinal Absorption; Male; Rats; Rats, Wistar; Solubility | 1998 |
The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
Topics: Albendazole; Animals; Anthelmintics; Anticestodal Agents; Buffaloes; Cattle; Drug Administration Schedule; Injections; Male; Metabolic Clearance Rate; Rumen | 1998 |
Echinococcus granulosus: membrane permeability of secondary hydatid cysts to albendazole sulfoxide.
Topics: Albendazole; Animals; Anticestodal Agents; Drug Therapy, Combination; Echinococcosis; Echinococcus; Fenbendazole; Gerbillinae; Guanidines; Membranes; Permeability | 1998 |
Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma.
Topics: Albendazole; Antiparasitic Agents; Chromatography, High Pressure Liquid; Cysticercosis; Humans; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 1998 |
In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Encephalitozoon; Encephalitozoon cuniculi; Fibroblasts; Humans | 1998 |
Effect of albendazole sulfoxide solution on the scolices and the hepatobiliary system.
Topics: Alanine Transaminase; Albendazole; Alkaline Phosphatase; Animals; Anticestodal Agents; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Cholangitis, Sclerosing; Echinococcosis, Hepatic; Echinococcus; gamma-Glutamyltransferase; Humans; In Vitro Techniques; Liver; Rabbits; Sheep; Time Factors | 1998 |
Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Echinococcosis; Echinococcus; Microscopy, Electron | 1999 |
Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Drug Interactions; Female; Fenbendazole; Guanidines; Sheep | 1999 |
Influence of diet type and pretreatment fasting on the disposition kinetics of albendazole in sheep.
Topics: Albendazole; Animal Feed; Animals; Anthelmintics; Biological Availability; Diet; Eating; Fasting; Metabolic Clearance Rate; Poaceae; Sheep | 1999 |
Stereoselective drug release from ketoprofen and ricobendazole matrix tablets.
Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Ketoprofen; Solubility; Stereoisomerism; Tablets | 1999 |
A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration.
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Injections, Intralesional; Liver; Sheep; Suction; Ultrasonography | 2000 |
Therapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis.
Topics: Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Drug Monitoring; Electrophoresis, Capillary; Humans; Reproducibility of Results; Sensitivity and Specificity | 2000 |
The in vitro secretion of acetylcholinesterase by adult stages of Heligmosomoides polygyrus: the effects of broad-spectrum anthelmintics.
Topics: Acetylcholinesterase; Albendazole; Animals; Anthelmintics; Colorimetry; Culture Media; Drug Evaluation, Preclinical; Female; Fetal Blood; Ivermectin; Levamisole; Male; Mebendazole; Mice; Morantel; Nematospiroides dubius; Serum Albumin, Bovine; Strongylida Infections | 2000 |
Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Female; Male; Sex Characteristics; Sheep; Statistics, Nonparametric; Stereoisomerism | 2000 |
Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Cattle; Chromatography, High Pressure Liquid; Fasting; Intestinal Mucosa; Male; Plasma; Time Factors; Tissue Distribution | 2000 |
Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites.
Topics: Albendazole; Animals; Anthelmintics; Ascaris suum; Cestoda; Cytosol; Fasciola hepatica; Helminthiasis, Animal; Microsomes; Oxidation-Reduction; Sheep; Sheep Diseases; Swine; Swine Diseases | 2001 |
Effect of ruminal microflora on the biotransformation of netobimin, albendazole, albendazole sulfoxide, and albendazole sulfoxide enantiomers in an artificial rumen.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Cattle; Chromatography, High Pressure Liquid; Fermentation; Guanidines; In Vitro Techniques; Models, Chemical; Rumen; Stereoisomerism | 2001 |
Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Injections, Intravenous; Male; Tissue Distribution | 2001 |
Pharmacokinetics of ricobendazole in calves.
Topics: Albendazole; Animals; Animals, Newborn; Anthelmintics; Area Under Curve; Cattle; Chromatography, High Pressure Liquid; Cross-Over Studies; Injections; Injections, Intravenous; Injections, Subcutaneous; Rumen | 2001 |
Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone.
Topics: Albendazole; Alkaline Phosphatase; Animals; Anthelmintics; Biomarkers; Echinococcus; Immunohistochemistry; In Vitro Techniques; Microscopy, Electron, Scanning | 2001 |
Comparative disposition of ricobendazole enantiomers after intravenous and subcutaneous administration of a racemic formulation to calves.
Topics: Albendazole; Algorithms; Animals; Anthelmintics; Area Under Curve; Biotransformation; Cattle; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Stereoisomerism; Sulfones | 2000 |
Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.
Topics: 2-Propanol; Albendazole; Anthelmintics; beta-Cyclodextrins; Chloroform; Cyclodextrins; Electrophoresis, Capillary; Humans; Indicators and Reagents; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2001 |
Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Ascaris suum; Chromatography, High Pressure Liquid; Fasciola hepatica; Sheep; Swine | 2001 |
Capillary electrophoresis with (R)-(--)-N-(3,5-dinitrobenzoyl)-alpha-phenylglycine as chiral selector for separation of albendazole sulfoxide enantiomers and their analysis in human plasma.
Topics: Albendazole; Anthelmintics; Electrophoresis, Capillary; Glycine; Humans; Nitrobenzoates; Stereoisomerism | 2002 |
In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: enantioselective sulphoreduction in sheep and cattle.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Benzimidazoles; Biotransformation; Body Fluids; Cattle; Drug Therapy, Combination; Isomerism; Sheep; Stomach, Ruminant | 2002 |
Placental transfer of albendazole sulphoxide enantiomers in sheep.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Female; Fetus; Gestational Age; Maternal-Fetal Exchange; Placental Circulation; Pregnancy; Sheep; Stereoisomerism | 2002 |
Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Female; Humans; Male; Middle Aged; Neurocysticercosis; Stereoisomerism | 2002 |
Effect of gender in the disposition of albendazole metabolites in humans.
Topics: Administration, Oral; Adult; Albendazole; Area Under Curve; Double-Blind Method; Female; Half-Life; Humans; Male; Sex Factors | 2002 |
Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma.
Topics: Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Separation of albendazole sulfoxide enantiomers by chiral supercritical-fluid chromatography.
Topics: Acetonitriles; Albendazole; Alcohols; Amylose; Carbamates; Cellulose; Chromatography, Supercritical Fluid; Phenylcarbamates; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Solutions; Stereoisomerism | 2002 |
Albendazole sulphoxide enantiomers in pregnant rats' embryo concentrations and developmental toxicity.
Topics: Abnormalities, Multiple; Administration, Oral; Albendazole; Animals; Anthelmintics; Bone and Bones; Embryonic and Fetal Development; Female; Limb Deformities, Congenital; Pregnancy; Rats; Rats, Sprague-Dawley | 2003 |
Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Antifungal Agents; Area Under Curve; Biotransformation; Clotrimazole; Drug Interactions; Half-Life; Liver; Male; Rats; Rats, Wistar | 2003 |
Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors.
Topics: Albendazole; Ampicillin; Animals; Benzimidazoles; Cyclosporine; Intestine, Small; Male; Metabolic Clearance Rate; Perfusion; Rats; Rats, Wistar; Sheep | 2003 |
The effects of albendazole and its metabolites on hepatic cytochromes P450 activities in mouflon and rat.
Topics: Albendazole; Animals; Anthelmintics; Blotting, Western; Cytochrome P-450 Enzyme System; Enzyme Induction; Formazans; Hepatocytes; Isoenzymes; Male; Microsomes, Liver; Rats; Sheep, Domestic; Tetrazolium Salts | 2003 |
Use of semipreparative supercritical fluid chromatography to obtain small quantities of the albendazole sulfoxide enantiomers.
Topics: Albendazole; Chromatography, Supercritical Fluid; Stereoisomerism | 2003 |
Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Herb-Drug Interactions; Injections, Intravenous; Intestinal Absorption; Jejunum; Male; Metabolic Clearance Rate; Panax; Perfusion; Plant Extracts; Rats; Rats, Wistar | 2003 |
Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Female; Half-Life; Sheep; Stereoisomerism | 2003 |
Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography.
Topics: Adult; Albendazole; Anthelmintics; Calibration; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2004 |
Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Biological Availability; Dose-Response Relationship, Drug; Echinococcosis; Echinococcus; Female; Mebendazole; Mice; Treatment Outcome | 2003 |
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Linear Models; Mebendazole; Mice; Povidone; Solubility; Time Factors | 2004 |
Effect of the ionophore antibiotic monensin on the ruminal biotransformation of benzimidazole anthelmintics.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Drug Interactions; Female; Guanidines; In Vitro Techniques; Ionophores; Monensin; Prodrugs; Rumen; Sheep; Statistics, Nonparametric | 2004 |
Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma.
Topics: Albendazole; Animals; Anthelmintics; Calibration; Chromatography, High Pressure Liquid; Sensitivity and Specificity; Sheep; Spectrometry, Fluorescence | 2004 |
Ex vivo anthelmintic activity of albendazole-sulphoxide enantiomers.
Topics: Albendazole; Animals; Anthelmintics; Disease Models, Animal; Larva; Male; Mice; Parasitic Sensitivity Tests; Stereoisomerism; Trichinella spiralis; Trichinellosis | 2004 |
Resistance to benzimidazole and macrocyclic lactone anthelmintics in cattle nematodes in Argentina.
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Argentina; Benzimidazoles; Cattle; Cattle Diseases; Drug Resistance; Feces; Haemonchiasis; Haemonchus; Ivermectin; Levamisole; Macrolides; Male; Parasite Egg Count; Parasitic Sensitivity Tests; Trichostrongyloidea; Trichostrongyloidiasis | 2004 |
Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.
Topics: Adult; Albendazole; Female; Humans; Kidney; Kinetics; Male; Middle Aged; Molecular Structure; Neurocysticercosis; Stereoisomerism | 2004 |
Quantitative determination of albendazole metabolites in sheep spermatozoa and seminal plasma by liquid chromatographic analysis with fluorescence detection.
Topics: Albendazole; Animals; Anthelmintics; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Freezing; Male; Molecular Structure; Semen; Sheep; Spermatozoa | 2004 |
A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement.
Topics: Albendazole; Amino Acid Sequence; Animals; Anthelmintics; Benzimidazoles; Binding Sites; Drug Resistance; Fasciola hepatica; Haemonchus; Helminth Proteins; Models, Chemical; Molecular Sequence Data; Mutation; Protein Structure, Tertiary; Tubulin | 2004 |
Analytical and semipreparative resolution of enatiomers of albendazole sulfoxide by HPLC on amylose tris (3,5-dimethylphenylcarbamate) chiral stationary phases.
Topics: Albendazole; Amylose; Chromatography, High Pressure Liquid; Isomerism; Phase Transition; Phenylcarbamates | 2005 |
[Influence of mobile phase composition on chiral separation of albendazole sulfoxide racemates].
Topics: 2-Propanol; Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Ethanol; Hexanes; Isomerism; Methanol; Stereoisomerism | 2004 |
Highly sensitive ion pair liquid chromatographic determination of albendazole marker residue in animal tissues.
Topics: Adipose Tissue; Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Kidney; Liver; Muscles; Pesticide Residues; Quality Control; Sensitivity and Specificity; Sheep | 2005 |
Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Albendazole; Algorithms; beta-Cyclodextrins; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Lipids; Pharmaceutical Solutions; Solubility; Spectrophotometry, Ultraviolet | 2005 |
Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Quantitative Structure-Activity Relationship; Reference Standards; Reproducibility of Results; Sheep | 2005 |
Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds.
Topics: Albendazole; Animals; Animals, Wild; Anthelmintics; Biotransformation; Cattle; Deer; Male; Microsomes, Liver; Oxidation-Reduction; Sheep; Swine | 2005 |
An in vitro kinetic method for detection of precipitation of poorly soluble drugs.
Topics: Albendazole; Chemical Precipitation; Drug Stability; Kinetics; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2005 |
Variation among faecal egg counts following natural nematode infection in Scottish Blackface lambs.
Topics: Albendazole; Analysis of Variance; Animals; Binomial Distribution; Feces; Ivermectin; Levamisole; Likelihood Functions; Linear Models; Parasite Egg Count; Scotland; Seasons; Sheep; Sheep Diseases; Time Factors; Trichostrongyloidea; Trichostrongyloidiasis | 2006 |
Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies.
Topics: Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred BALB C; Praziquantel; Taenia; Time Factors | 2006 |
Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep.
Topics: Albendazole; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Cattle; Dogs; Drug Resistance, Multiple; Enrofloxacin; Female; Flavanones; Fluoroquinolones; Genistein; Humans; Injections, Intramuscular; Injections, Intravenous; Lactation; Mammary Glands, Animal; Mice; Milk; Neoplasm Proteins; Sheep | 2006 |
Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.
Topics: Albendazole; Animals; Anticestodal Agents; Cysticercosis; Drug Combinations; Drug Synergism; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nitro Compounds; Parasitic Sensitivity Tests; Taenia; Thiazoles | 2007 |
Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Biotransformation; Chromatography, High Pressure Liquid; Indicators and Reagents; Praziquantel; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Swine | 2007 |
Absorption and metabolism of albendazole after intestinal ischemia/reperfusion.
Topics: Albendazole; Animals; Anthelmintics; Cytochrome P-450 CYP3A; Ileum; Intestinal Absorption; Jejunum; Male; Microsomes; Oxygenases; Permeability; Rats; Rats, Wistar; Reperfusion Injury; Tubulin Modulators | 2007 |
Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Isomerism; Rats | 2008 |
Kinetic disposition of albendazole in goats subclinically infected with gastrointestinal nematodes vis-à-vis naive animals following oral and intraruminal administration.
Topics: Administration, Oral; Albendazole; Animals; Animals, Domestic; Antinematodal Agents; Biological Availability; Feces; Female; Goat Diseases; Goats; Half-Life; Nematoda; Nematode Infections; Parasite Egg Count; Rumen | 2008 |
LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, Liquid; Haemonchus; Mass Spectrometry; Mebendazole; Oxidation-Reduction | 2008 |
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.
Topics: Albendazole; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Line; Cyclosporins; Dibenzocycloheptenes; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Ivermectin; LLC-PK1 Cells; Mice; Quinolines; Ritonavir; Swine; Time Factors; Topotecan; Transfection | 2008 |
Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Dicrocoeliasis; Dicrocoelium; Female; Liver Diseases; Reproducibility of Results; Sheep; Sheep Diseases | 2009 |
Synthesis and in vitro cysticidal activity of new benzimidazole derivatives.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Drug Design; Models, Molecular; Reference Standards; Taenia | 2009 |
Determination of albendazole metabolites by direct injection of bovine plasma and multidimensional achiral-chiral high performance liquid chromatography.
Topics: Albendazole; Animals; Cattle; Chromatography, High Pressure Liquid; Injections; Polysaccharides; Reproducibility of Results; Stereoisomerism | 2008 |
Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Binding, Competitive; Chromatography, Gel; Cytosol; Fasciola hepatica; Fascioliasis; Helminth Proteins; Liver Diseases, Parasitic; Microsomes; Protein Binding; Sheep; Sheep Diseases; Stereoisomerism; Triclabendazole | 2009 |
Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats.
Topics: Aging; Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Female; Goats; Male; Regression Analysis; Sex Characteristics | 2009 |
Diagnosis and treatment of pulmonary cystic hydatidosis.
Topics: Adolescent; Albendazole; Anticestodal Agents; Child; Echinococcosis, Pulmonary; Female; Follow-Up Studies; Humans; Male; Retrospective Studies; Treatment Outcome; Turkey | 2008 |
Pharmacological assessment of netobimin as a potential anthelmintic for use in horses: plasma disposition, faecal excretion and efficacy.
Topics: Albendazole; Animals; Anthelmintics; Calibration; Feces; Guanidines; Helminthiasis; Horse Diseases; Horses; Intestinal Absorption; Sulfones; Tissue Distribution | 2009 |
Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study).
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis, Hepatic; Echinococcus granulosus; Humans; In Vitro Techniques; Solutions | 2009 |
[In vitro observation on albendazole sulfoxide and its enantiomers against Echinococcus granulosus protoscolex].
Topics: Albendazole; Animals; Anthelmintics; Echinococcus granulosus | 2008 |
Stability of ricobendazole in aqueous solutions.
Topics: Albendazole; Anthelmintics; Buffers; Catalysis; Cations; Chromatography, High Pressure Liquid; Copper; Drug Stability; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Least-Squares Analysis; Linear Models; Mass Spectrometry; Models, Biological; Molecular Structure; Oxidants; Oxidation-Reduction; Solutions; Spectrophotometry, Ultraviolet; Temperature; Water | 2009 |
Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.
Topics: Adult; Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Echinococcus granulosus; Humans; Middle Aged | 2009 |
Population pharmacokinetics of albendazole in patients with neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Models, Biological; Neurocysticercosis; Nonlinear Dynamics; Prospective Studies; Young Adult | 2009 |
Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Breast Feeding; Chromatography, High Pressure Liquid; Egypt; Female; Humans; Infant; Milk, Human; Regression Analysis; Young Adult | 2009 |
In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo.
Topics: Albendazole; Animals; Biotransformation; Dicrocoelium; Enzyme Inhibitors; Glutathione Peroxidase; Oxidation-Reduction; Sheep; Subcellular Fractions; Xenobiotics | 2010 |
In vitro evaluation of the effects of cysticidal drugs in the Taenia crassiceps cysticerci ORF strain using the fluorescent CellTracker CMFDA.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Cysticercus; Female; Fluoresceins; Fluorescent Dyes; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Praziquantel | 2011 |
Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Albendazole; Animals; Anthelmintics; beta-Cyclodextrins; Creatine Kinase; Excipients; Female; Injections, Subcutaneous; Pharmaceutical Solutions; Sheep; Solubility | 2010 |
Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
Topics: Albendazole; Animals; beta-Cyclodextrins; Biological Availability; Cell Line; Chemistry, Pharmaceutical; Drug Carriers; Emulsions; Fibroblasts; Hydrogen-Ion Concentration; Injections; Injections, Subcutaneous; L-Lactate Dehydrogenase; Pharmaceutical Solutions; Sheep | 2010 |
Microbial transformation of albendazole.
Topics: Albendazole; Anthelmintics; Biotransformation; Gram-Negative Bacteria | 2010 |
Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.
Topics: Albendazole; Animals; Anthelmintics; Caenorhabditis elegans; Chromatography, High Pressure Liquid; Drug Resistance; Enzyme Induction; Fenofibrate; Gene Expression Profiling; Glucosides; Intestines; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Mutation; Oligonucleotide Array Sequence Analysis; PPAR alpha; Tandem Mass Spectrometry; Tubulin | 2010 |
The transport of albendazole and albendazole sulphoxide in the lancet fluke (Dicrocoelium dendriticum).
Topics: Albendazole; Animals; Anthelmintics; Biological Transport; Dicrocoelium | 2011 |
Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Drug Stability; Female; Least-Squares Analysis; Liquid-Liquid Extraction; Reproducibility of Results; Sensitivity and Specificity; Turkeys | 2011 |
Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Dogs; Female; Male | 2011 |
Highly sensitive LC-MS/MS-ESI method for simultaneous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study.
Topics: Albendazole; Animals; Chromatography, Liquid; Drug Stability; Linear Models; Male; Phenacetin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Evaluation of potential embryo toxicity of albendazole sulphoxide in CF1 mice.
Topics: Albendazole; Animals; Anthelmintics; Blastocyst; Embryo, Mammalian; Female; Humans; Male; Mice; Pregnancy; Teratogens | 2011 |
A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.
Topics: Albendazole; Anthelmintics; Chromatography, Liquid; Drug Stability; Humans; Linear Models; Neurocysticercosis; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Capillary electrophoresis and hollow fiber liquid-phase microextraction for the enantioselective determination of albendazole sulfoxide after biotransformation of albendazole by an endophytic fungus.
Topics: 1-Octanol; Acetates; Albendazole; Biotransformation; Drug Stability; Electrophoresis, Capillary; Liquid Phase Microextraction; Osmolar Concentration; Penicillium; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2011 |
Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Biotransformation; Carps; Chromatography, High Pressure Liquid; Drug Residues; Half-Life; Metabolic Clearance Rate; Models, Biological; Reproducibility of Results; Spectrophotometry, Ultraviolet; Temperature; Tissue Distribution | 2012 |
Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode.
Topics: Albendazole; Ascomycota; Biotransformation; Chromatography, High Pressure Liquid; Stereoisomerism | 2012 |
Albendazole sulfoxide enantiomers: preparative chiral separation and absolute stereochemistry.
Topics: Albendazole; Chromatography; Circular Dichroism; Molecular Conformation; Stereoisomerism | 2012 |
Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines.
Topics: Albendazole; Anthelmintics; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Chromatography, High Pressure Liquid; Circular Dichroism; Humans; Neoplasms; Optical Rotation; Stereoisomerism | 2012 |
Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: the rat whole embryo culture and the mouse embryonic stem cell test.
Topics: Albendazole; Animals; Antiparasitic Agents; Cell Differentiation; Cell Line; Embryo, Mammalian; Embryonic Stem Cells; Female; Male; Mice; Myocytes, Cardiac; Rats; Rats, Wistar; Toxicity Tests | 2012 |
In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.
Topics: Albendazole; Alkaline Phosphatase; Animals; Anticestodal Agents; Neurocysticercosis; Praziquantel; Stereoisomerism; Swine; Taenia solium | 2013 |
RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci.
Topics: Actins; Albendazole; Animals; Anthelmintics; Benzimidazoles; Cysticercus; Gene Expression; Immunochemistry; Microscopy; Myosin Type II; Taenia; Tubulin | 2013 |
Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice.
Topics: Albendazole; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cyclosporine; Encephalitozoon cuniculi; Encephalitozoonosis; Immunocompromised Host; Intestines; Kidney; Liver; Lung; Male; Metronidazole; Mice; Mice, Inbred BALB C; Spleen | 2013 |
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators | 2013 |
In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
Topics: Albendazole; Animals; Anticestodal Agents; Disease Models, Animal; Echinococcosis; Echinococcus granulosus; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Sheep | 2013 |
Historic of therapeutic efficacy of albendazol sulphoxide administered in different routes, dosages and treatment schemes, against Taenia saginata cysticercus in cattle experimentally infected.
Topics: Administration, Oral; Albendazole; Animals; Anticestodal Agents; Cattle; Cattle Diseases; Cysticercosis; Cysticercus; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Taenia saginata | 2014 |
Effect of the water content on the retention and enantioselectivity of albendazole and fenbendazole sulfoxides using amylose-based chiral stationary phases in organic-aqueous conditions.
Topics: Acetonitriles; Albendazole; Amylose; Benzimidazoles; Chromatography, High Pressure Liquid; Ethanol; Fenbendazole; Methanol; Stereoisomerism; Sulfides; Sulfones; Sulfoxides; Water | 2014 |
Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Drug Interactions; Drug Resistance; Feces; Female; Ivermectin; Levamisole; Male; Nematoda; Nematode Infections; Parasite Egg Count; Sheep; Sheep Diseases; Time | 2014 |
Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis.
Topics: Albendazole; Animals; Anthelmintics; Chemoprevention; Echinococcosis; Echinococcus granulosus; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Poloxamer; Treatment Outcome | 2014 |
Albendazolesulphoxide concentrations in plasma and hydatid cyst and prediction of parasitological and clinical outcomes in patients with liver hydatidosis caused by Echinococcus granulosus.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Biological Availability; Child; Echinococcosis, Hepatic; Echinococcus granulosus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Young Adult | 2014 |
Isolation and identification of Paenibacillus sp. FM-6, involved in the biotransformation of albendazole.
Topics: Albendazole; Animals; Anthelmintics; Aquaculture; Biotransformation; Fishes; Hydrogen-Ion Concentration; Paenibacillus; Phylogeny; Temperature; Water Microbiology | 2014 |
Effects of feeding on the plasma disposition kinetics of the anthelmintic albendazole in laying hens.
Topics: Albendazole; Animals; Anthelmintics; Chickens; Diet; Female; Food Deprivation | 2014 |
[Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Topics: Albendazole; Animals; Chitosan; Echinococcosis; Echinococcus granulosus; Male; Mice; Microspheres | 2014 |
Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography tandem triple quadrupole mass spectrometry.
Topics: Albendazole; Analytic Sample Preparation Methods; Animals; Antiparasitic Agents; Bombyx; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Freezing; Hemolymph; Limit of Detection; Linear Models; Liquid-Liquid Extraction; Tandem Mass Spectrometry; Time Factors | 2014 |
The effect of anthelmintic resistance on the productivity in feedlot cattle.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Cattle Diseases; Drug Resistance; Feces; Ivermectin; Levamisole; Parasite Egg Count; Trichostrongyloidea; Trichostrongyloidiasis | 2014 |
The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats.
Topics: Albendazole; Animal Nutritional Physiological Phenomena; Animals; Biotransformation; Diet, Protein-Restricted; Disease Models, Animal; Liver; Male; Microsomes, Liver; Nutritional Status; Oxidation-Reduction; Protein-Energy Malnutrition; Rats, Wistar | 2015 |
Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
Topics: Administration, Intravenous; Albendazole; Animals; Anthelmintics; Area Under Curve; Dose-Response Relationship, Drug; Female; Goats; Half-Life; Injections, Subcutaneous; Male; Sheep; Species Specificity | 2015 |
Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Topics: Administration, Intranasal; Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Curcumin; Docosahexaenoic Acids; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Stability; Emulsions; Female; In Vitro Techniques; Male; Nasal Absorption; Neurocysticercosis; Neurons; Pharmaceutical Vehicles; Rats, Sprague-Dawley; Sheep, Domestic; Tissue Distribution | 2015 |
Alternative energy production pathways in Taenia crassiceps cysticerci in vitro exposed to a benzimidazole derivative (RCB20).
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Albendazole; Animals; Anticestodal Agents; Benzimidazoles; Creatinine; Culture Media; Cysticercus; Energy Metabolism; Fumarates; Mice; Propionates; Proteins; Taenia; Urea | 2016 |
Determination of albendazole sulfoxide in human plasma by using liquid chromatography-tandem mass spectrometry.
Topics: Albendazole; Chromatography, Liquid; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |
Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Topics: Albendazole; Chemistry, Pharmaceutical; Desiccation; Drug Carriers; Drug Compounding; Drug Stability; Freezing; Hot Temperature; Hydrochloric Acid; Mesylates; Polyethylene Glycols; Polymers; Polymethacrylic Acids; Polyvinyls; Povidone; Solubility; Sulfuric Acids | 2017 |
Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces.
Topics: Albendazole; Animals; Anthelmintics; Apoptosis; Caspase 3; Echinococcosis; Echinococcus granulosus; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Anti-helminthic activity of Momordica charantia L. against Fasciola hepatica eggs after twelve days of incubation in vitro.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Cattle Diseases; Chromatography, High Pressure Liquid; Fasciola hepatica; Fascioliasis; Feces; Female; Flavonoids; Momordica charantia; Ovum; Parasite Egg Count; Plant Extracts; Plant Leaves; Plants, Medicinal; Quercetin | 2016 |
Nitazoxanide induces in vitro metabolic acidosis in Taenia crassiceps cysticerci.
Topics: Albendazole; Animals; Anticestodal Agents; Antiparasitic Agents; Female; Glucose; Glycolysis; Lactic Acid; Mice; Mice, Inbred BALB C; Nitro Compounds; Pyruvic Acid; Taenia; Thiazoles | 2016 |
Assessment of liver slices for research on metabolic drug-drug interactions in cattle.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Cattle; Drug Interactions; Liver; Methimazole; Microsomes, Liver; Stereoisomerism | 2017 |
A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.
Topics: Albendazole; Animals; Anticestodal Agents; Benzimidazoles; Citric Acid Cycle; Cysticercus; Energy Metabolism; Glucose; Glycolysis | 2017 |
LC-MS/MS methods for albendazole analysis in feed and its metabolite residues in fish fillet and a leaching study in feed after an alternative procedure for drug incorporation.
Topics: Albendazole; Animal Feed; Animals; Anthelmintics; Biotransformation; Brazil; Cellulose; Characiformes; Chromatography, Liquid; Coated Materials, Biocompatible; Drug Liberation; Drug Residues; Guidelines as Topic; Humans; Kinetics; Limit of Detection; Liquid-Liquid Extraction; Meat; Tandem Mass Spectrometry | 2017 |
Characterizations and bioactivities of abendazole sulfoxide-loaded thermo-sensitive hydrogel.
Topics: Albendazole; Animals; Anthelmintics; Caenorhabditis elegans; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Polyesters; Polyethylene Glycols | 2017 |
Resistant nematodes in cattle: Pharmaco-therapeutic assessment of the ivermectin- ricobendazole combination.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Cattle Diseases; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Ivermectin; Male; Nematode Infections; Parasite Egg Count; Random Allocation; Treatment Outcome | 2017 |
The sodium salt of the enantiomers of ricobendazole: Preparation, solubility and chiroptical properties.
Topics: Albendazole; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Sodium; Solubility; Stereoisomerism | 2017 |
Exposure of Heligmosomoides polygyrus and Trichuris muris to albendazole, albendazole sulfoxide, mebendazole and oxantel pamoate in vitro and in vivo to elucidate the pathway of drug entry into these gastrointestinal nematodes.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Gastrointestinal Tract; Injections, Intraperitoneal; Mebendazole; Mice; Nematospiroides dubius; Plasma; Pyrantel Pamoate; Trichuris | 2017 |
Pharmaco-parasitological evaluation of the ricobendazole plus levamisole nematodicidal combination in cattle.
Topics: Albendazole; Animals; Antinematodal Agents; Cattle; Cattle Diseases; Drug Therapy, Combination; Haemonchiasis; Haemonchus; Injections, Subcutaneous; Levamisole; Male; Ostertagia; Ostertagiasis; Parasite Egg Count; Seasons | 2018 |
A benzimidazole derivative (RCB15) in vitro induces the alternative energetic metabolism and glycolysis in Taenia crassiceps cysticerci.
Topics: Albendazole; Animals; Anticestodal Agents; Benzimidazoles; Cysticercus; Dose-Response Relationship, Drug; Energy Metabolism; Glucose; Glycolysis; Lactic Acid; Oxidation-Reduction; Pyruvic Acid | 2017 |
Application of Fluorescence Emission for Characterization of Albendazole and Ricobendazole Micellar Systems: Elucidation of the Molecular Mechanism of Drug Solubilization Process.
Topics: Albendazole; Deoxycholic Acid; Fluorescence; Micelles; Poloxamer; Polysorbates; Sodium Cholate; Solubility; Spectrometry, Fluorescence; Surface-Active Agents; Thermodynamics | 2018 |
Comparative proteomics analysis of Trichinella spiralis muscle larvae exposed to albendazole sulfoxide stress.
Topics: Albendazole; Animals; Anthelmintics; Female; Larva; Mice; Mice, Inbred BALB C; Proteomics; Real-Time Polymerase Chain Reaction; Trichinella spiralis | 2018 |
Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites.
Topics: Albendazole; Animals; Anthelmintics; Biochemical Phenomena; Biotransformation; Drug Resistance; Female; Haemonchiasis; Haemonchus; Male; Mebendazole; Sex Factors; Sheep; Sheep Diseases; Tandem Mass Spectrometry | 2018 |
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole | 2018 |
Repositioning of Anti-parasitic Drugs in Cyclodextrin Inclusion Complexes for Treatment of Triple-Negative Breast Cancer.
Topics: Albendazole; Animals; Antiparasitic Agents; beta-Cyclodextrins; Biological Availability; Cell Proliferation; Cyclodextrins; Drug Repositioning; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Random Allocation; Treatment Outcome; Triple Negative Breast Neoplasms; X-Ray Diffraction | 2018 |
Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis.
Topics: Adult; Age Factors; Albendazole; Anthelmintics; Dexamethasone; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neurocysticercosis; Prednisone; Treatment Outcome | 2019 |
Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Female; Humans; Male; Mass Spectrometry; Middle Aged; Neurocysticercosis; Praziquantel; Young Adult | 2019 |
New HPLC-MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration.
Topics: Administration, Oral; Albendazole; Animals; Chromatography, High Pressure Liquid; Diethylcarbamazine; Doxycycline; Plasma; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2019 |
In vitro nitazoxanide exposure affects energetic metabolism of Taenia crassiceps.
Topics: Albendazole; Analysis of Variance; Animals; Anthelmintics; Antiparasitic Agents; Citrates; Citric Acid Cycle; Culture Media; Cysticercus; Energy Metabolism; Fumarates; Ketoglutaric Acids; Malates; Neurocysticercosis; Nitro Compounds; Oxaloacetic Acid; Succinic Acid; Taenia; Thiazoles | 2020 |
Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug.
Topics: Albendazole; Animals; Anthelmintics; Cross-Over Studies; Dogs; Female; Male; Nanoparticles; Particle Size; Spray Drying | 2020 |
Design of novel oral ricobendazole formulation applying melting solidification printing process (MESO-PP): An innovative solvent-free alternative method for 3D printing using a simplified concept and low temperature.
Topics: Albendazole; Drug Liberation; Printing, Three-Dimensional; Solvents; Spectroscopy, Fourier Transform Infrared; Tablets; Technology, Pharmaceutical; Temperature | 2020 |
Sub-lethal doses of albendazole induce drug metabolizing enzymes and increase albendazole deactivation in Haemonchus contortus adults.
Topics: Albendazole; Animals; Antinematodal Agents; Dose-Response Relationship, Drug; Drug Resistance; Haemonchus; Inactivation, Metabolic | 2020 |
Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice.
Topics: Albendazole; Animals; Anticestodal Agents; Echinococcosis; Echinococcus granulosus; Female; Mice; Mice, Inbred BALB C; Salts | 2020 |
A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide.
Topics: Administration, Oral; Albendazole; Biological Availability; Computer Simulation; Humans; Solubility | 2020 |
Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Topics: Administration, Oral; Albendazole; Animals; Antiplatyhelmintic Agents; Chitosan; Drug Delivery Systems; Drug Evaluation, Preclinical; Echinococcosis; Echinococcus granulosus; Mice; Nanoparticles; Polyglycolic Acid | 2020 |
A new approach for microextraction of trace albendazole sulfoxide drug from the samples of human plasma and urine, and water by the molecularly imprinted polymer nanoparticles combined with HPLC.
Topics: Albendazole; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Linear Models; Molecular Imprinting; Molecularly Imprinted Polymers; Nanoparticles; Reproducibility of Results; Solid Phase Microextraction; Water | 2020 |
In vivo exposure of Albendazole sulphoxide by Haemonchus contortus and correlation between plasma and target tissue or gastrointestinal content dispositions in goats.
Topics: Albendazole; Animals; Anthelmintics; Female; Gastrointestinal Contents; Goat Diseases; Goats; Haemonchus; Male; Pharmaceutical Preparations; Sheep; Sheep Diseases | 2021 |
Mathematical and Pharmacokinetic Approaches for the Design of New 3D Printing Inks Using Ricobendazole.
Topics: Albendazole; Animals; Delayed-Action Preparations; Excipients; Ink; Polymers; Printing, Three-Dimensional; Surface-Active Agents; Tablets | 2022 |